Latest filing published 16 Feb 2024 for Sensei Biotherapeutics, Inc., €2,670.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Erin Colgan: trading record in brief
Erin Colgan is a declared insider of Faeth Therapeutics, Inc. (finance chief), with filings sourced from SEC (Form 4). We count 7 filings; the first trade dates from 15 February 2022 and the latest from 15 February 2024.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
Most recently, on 16 February 2024, the filings show a share grant worth €2,670 in Faeth Therapeutics, Inc. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Erin Colgan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,627 shares@ US$0.7914.9% of flowCommon StockSEC:0001415889-24-004234:0
- 10,943 shares@ US$1.5085.1% of flowCommon StockSEC:0001209191-23-048965:0
- 30,046 shares0Common StockSEC:0001209191-23-021542:0
- 30,046 shares0Common StockSEC:0001209191-23-010735:0
- 21,000 shares0Common StockSEC:0001209191-22-010978:0
5 of 5 declarations
